Empresa Wayland Group Corp Canadian Securities Exchange
Acciones
CA5667241007
Farmacéuticos
Resumen de negocios
Ventas por actividad
USD en millones | 2016 | Peso | 2017 | Peso | Delta |
---|---|---|---|---|---|
Marijuana Production for Medical Purposes
100,0
%
| 3 | 100,0 % | 2 | 100,0 % | -18,98 % |
Ventas por región
USD en millones | 2016 | Peso | 2017 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 3 | 100,0 % | 2 | 100,0 % | -18,98 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Dan Healey
COO | Chief Operating Officer | - | - |
Steven Bennett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | - | |
Geoff Kosar
SAM | Sales & Marketing | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 237 260 499 | 237 260 499 ( 100,00 %) | 0 | 100,00 % |
Información de la empresa
Wayland Group Corp.
845 Harrington Court Unit 3
L7N 3P3, Burlington
+289-288-6274
![Dirección Wayland Group Corp](https://cdn.zonebourse.com/static/address/34637464.png)
Varia. 1 de ene. | Capi. | |
---|---|---|
+27,29 % | 5560,06 M | |
-33,07 % | 3547,6 M | |
-3,24 % | 3009,1 M | |
-24,56 % | 2638,09 M | |
-10,17 % | 2302,09 M | |
+46,81 % | 1948,21 M | |
+48,03 % | 1522,13 M | |
-11,69 % | 1448,06 M | |
+43,81 % | 1382,19 M |